BioCryst Pharmaceuticals | BCRX - Stock


BioCryst Pharmaceuticals reported $6.06M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Chugai Pharma JPY 276.85B 30.52B Dec/2025
Daiichi Sankyo JPY 692.38B 83.83B Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Glaxosmithkline GBP 6.16B 39M Mar/2026
Incyte USD 112.54M 3.08M Jun/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
Novavax USD 10.01M 1.45M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026